文献速递神经创伤

开颅手术与急性硬膜下血肿患者结局的关联:日本全国创伤登记分析

Association Between Craniotomy and Outcomes in Patients With Acute Subdural Hematoma: Analysis of a Nationwide Trauma Registry in Japan.
PubMed 文献 · Neurosurgery · 2026-10-30

这项多中心队列研究分析日本创伤数据库2019至2023年数据,纳入1808例成人大型幕上急性硬膜下血肿且入院GCS 6-15分患者,经倾向评分匹配比较开颅与否的结局。开颅与出院生存率显著提高相关(77.2% vs 62.6%),但良好神经功能结局无显著差异;年龄≥65岁和GCS 6-12分者获益更明显。

要点

  • 开颅与大型急性硬膜下血肿患者出院生存率提高相关,但良好神经功能结局无显著改善。
  • 年龄≥65岁和GCS 6-12分患者从开颅中获益更明显,GCS 13-15分者未见获益。
  • 仅依据血肿厚度决定手术可能不够,应结合年龄和神经功能严重程度个体化决策。

核心结论

  • 大型急性硬膜下血肿患者中,开颅与出院生存率提高显著相关,尤其≥65岁和GCS 6-12分者。
  • 开颅与出院良好神经功能结局比例无显著差异。
  • 仅基于血肿厚度的统一手术策略可能不理想,需结合年龄和神经功能严重程度个体化决策。

研究设计与样本

  • 多中心队列研究,分析日本创伤数据库2019年1月至2023年12月数据。
  • 纳入≥18岁、大型幕上急性硬膜下血肿(>50 cm3,>1 cm厚)且入院GCS 6-15分患者。
  • 共纳入83家医院1808例患者,中位年龄79岁,男性64.9%,46.6%接受开颅。
  • 采用1:1倾向评分匹配比较开颅与未开颅患者,匹配后各610例。

主要发现

  • 匹配后开颅组出院生存率77.2%,未开颅组62.6%,组内差异14.7%(95% CI 9.6%-19.8%)。
  • 匹配后良好神经功能结局比例开颅组16.1%,未开颅组17.9%,组内差异-1.9%(95% CI -7.5%至3.7%),无显著差异。
  • 亚组分析显示开颅与年龄和GCS评分存在显著交互作用。
  • 年龄<65岁差异3.9%,≥65岁差异17.1%;GCS 6-12分差异27.8%,GCS 13-15分差异-6.1%。
  • 各医院开颅率范围0.0%至83.3%,中位数46.2%。

临床怎么用

  • 对大型急性硬膜下血肿患者,开颅可考虑用于提高生存率,尤其≥65岁或GCS 6-12分者。
  • GCS 13-15分患者开颅未见生存或神经功能获益,决策需谨慎。
  • 手术决策应结合年龄和神经功能严重程度个体化,而非仅依据血肿厚度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The benefits of surgery remain unclear in less severe cases of acute subdural hematoma (ASDH). We aimed to investigate the association between surgical intervention and outcomes in patients with ASDH. METHODS: This multicenter cohort study analyzed data from the Japan Trauma Data Bank between January 2019 and December 2023. Patients age 18 years and older with large supratentorial ASDH (>50 cm3, >1 cm thick) and a Glasgow Coma Scale (GCS) score of 6 to 15 at hospital arrival were included. One-to-one propensity score matching was performed to compare patients who underwent craniotomy with those who did not. Study outcomes included survival to hospital discharge and favorable neurological outcomes. RESULTS: Overall, 1808 patients (median age, 79 years; 64.9% male) from 83 hospitals were included, and 46.6% underwent craniotomy. Craniotomy rates ranged from 0.0% to 83.3% (median, 46.2%) across hospitals. Propensity score matching identified 610 matched patients with and without craniotomy. Patients who underwent craniotomy had a significantly higher survival rate (77.2% vs 62.6%; within-hospital difference, 14.7%; 95% CI, 9.6%-19.8%); however, no significant difference was observed in the proportion of favorable neurological outcomes at discharge (16.1% vs 17.9%; within-hospital difference, -1.9%; 95% CI, -7.5% to 3.7%). Subgroups analyses demonstrated significant interactions between craniotomy and both age and GCS scores, with greater benefit observed in patients age 65 years and older (difference, 3.9% [<65 years] vs 17.1% [≥65 years]) and in those with a GCS score of 6 to 12 (difference, 27.8% [GCS 6-12] vs -6.1% [GCS 13-15]). CONCLUSION: In patients with large ASDHs, craniotomy was significantly associated with improved survival, particularly among patients age 65 years and older and those with lower GCS scores (6-12). A uniform approach based solely on hematoma thickness may be suboptimal. Instead, surgical decision-making needs to adopt a more individualized approach that incorporates age and neurological severity.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Shibahashi, Inoue, Kato, et al. Association Between Craniotomy and Outcomes in Patients With Acute Subdural Hematoma: Analysis of a Nationwide Trauma Registry in Japan. Neurosurgery. 2026. PMID: 42961038. doi:10.1227/neu.0000000000004265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。